birkhäuser basel springer basel nov 2004 (3 Ergebnisse)

Buch. Zustand: Neu. Neuware -Der Autor informiert über die unterschiedlichen Bestimmungen in den Landesbauordnungen, Normen und Gesetzen sowie über die brandtechnischen Eigenschaften von Baustoffen und Bauteilen. Neben den Anforderungen für den Wohnungsbau werden auch die Bestimmungen für den Industrie- und Sonderbau sowie die Möglichkeiten und Probleme bei der Sanierung von Gebäuden behandelt.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 360 pp. Deutsch.

Taschenbuch. Zustand: Neu. Neuware -Exciting developments in earthquake science have benefited from new observations, improved computational technologies, and improved modeling capabilities. Designing models of the earthquake generation process is a grand scientific challenge due to the complexity of phenomena and range of scales involved from microscopic to global. Such models provide powerful new tools for the study of earthquake precursory phenomena and the earthquake cycle.Through workshops, collaborations and publications, the APEC Cooperation for Earthquake Simulations (ACES) aims to develop realistic supercomputer simulation models for the complete earthquake generation process, thus providing a 'virtual laboratory' to probe earthquake behavior.Part II of the book embraces dynamic rupture and wave propagation, computational environment and algorithms, data assimilation and understanding, and applications of models to earthquakes. This part also contains articles on the computational approaches and challenges of constructing earthquake models.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 356 pp. Englisch.

Buch. Zustand: Neu. Neuware -Is it advisable to go back from bedside to the bench During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 340 pp. Englisch.